Alfredo Zurlo
Keine laufenden Positionen mehr
Profil
Alfredo Zurlo served as Co-Managing Director at Glycotope GmbH.
He then worked as Chief Medical Officer at MOLOGEN AG from 2013 to 2016.
After that, he served as Chief Medical Officer at Scandion Oncology A.
Zurlo holds a doctorate degree from The American University of Rome.
Ehemalige bekannte Positionen von Alfredo Zurlo
Unternehmen | Position | Ende |
---|---|---|
MOLOGEN AG | Technik-/Wissenschafts-/F&E-Leiter | 31.03.2016 |
SCANDION ONCOLOGY A/S | Technik-/Wissenschafts-/F&E-Leiter | - |
Glycotope GmbH
Glycotope GmbH BiotechnologyHealth Technology Glycotope GmbH operates as a biotechnology company to develop pharmaceutical therapeutics and nutrition additives. It focuses on the optimization and humanization of therapeutically relevant sugar structures on biopharmaceuticals known as glycosylation and on the development of innovative antibodies targeting glycostructures on cell surfaces. The company was founded by Steffen Goletz and Andreas Eckert in Febraury 2001 and is headquartered in Berlin, Germany. | Vorstandsvorsitzender | - |
Ausbildung von Alfredo Zurlo
The American University of Rome | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
MOLOGEN AG | Commercial Services |
SCANDION ONCOLOGY A/S | Health Technology |
Private Unternehmen | 1 |
---|---|
Glycotope GmbH
Glycotope GmbH BiotechnologyHealth Technology Glycotope GmbH operates as a biotechnology company to develop pharmaceutical therapeutics and nutrition additives. It focuses on the optimization and humanization of therapeutically relevant sugar structures on biopharmaceuticals known as glycosylation and on the development of innovative antibodies targeting glycostructures on cell surfaces. The company was founded by Steffen Goletz and Andreas Eckert in Febraury 2001 and is headquartered in Berlin, Germany. | Health Technology |